6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0028 770-25-1-801-0018 -National CMOP METFORMIN HCL
ID: 36C77025Q0028Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/847332e526f74c64b6a61c9595a8a961/view
Timeline
    Description

    The Department of Veterans Affairs is seeking quotations for the emergency procurement of Metformin HCL 500mg 24HR SA Tablets, with a presolicitation notice issued under solicitation number 36C77025Q0028. The procurement involves multiple quantities of the medication to be delivered to various VA Consolidated Mail Outpatient Pharmacy (CMOP) locations across the United States, emphasizing the importance of timely and compliant pharmaceutical distribution to meet the needs of veterans. Interested vendors must submit their quotes, including a price schedule in Excel format, proof of state wholesale distributor licensure in compliance with the Drug Supply Chain Security Act, and other required documentation by October 21, 2024, at 09:00 AM CST, with an estimated award date of October 24, 2024. For further inquiries, vendors can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.

    Point(s) of Contact
    Michael W McAlhaneyContracting Specialist
    Michael.McAlhaney@va.gov
    Files
    Title
    Posted
    36C77025Q0028_1.docx
    This document is a solicitation (36C77025Q0028) issued by the Department of Veterans Affairs for the procurement of pharmaceutical products, specifically Metformin HCL 500MG. The Request for Proposals (RFP) outlines requirements for vendors, including the necessity for products to be shippable by USPS and compliance with the Drug Supply Chain Security Act (DSCSA). Vendors are expected to submit detailed quotations that include price schedules, state licensing, and certifications related to trade agreements. The delivery schedule mandates timely shipments to various VA Consolidated Mail Outpatient Pharmacy (CMOP) locations. The RFP stipulates that all pharmaceutical products must have appropriate barcoding for tracking, adhere to regulatory approval standards, and provide a minimum shelf life of twelve months. In addition, vendors must ensure proper labeling and compliance with all federal and state regulations regarding pharmaceuticals. The document emphasizes the importance of adhering to the outlined terms and conditions to facilitate a smooth procurement process while ensuring that the needs of veterans are adequately met.
    36C77025Q0028.docx
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for an emergency procurement of Metformin HCL 500mg tablets, with a request for quotes (RFP) under solicitation number 36C77025Q0028. The procurement involves multiple quantities of the medication to be delivered to various VA Consolidated Mail Outpatient Pharmacy (CMOP) locations across the USA, with a response deadline set for October 21, 2024, at 09:00 AM CST. Quotes must be submitted via email to the designated contact, Michael McAlhaney. Vendors are required to provide a price schedule in Excel format, proof of state wholesale distributor licensure in compliance with the Drug Supply Chain Security Act, and other relevant documentation as part of their submission. The estimated award date is October 24, 2024, with a delivery timeframe of 10 days after receipt of order. This notice emphasizes adherence to trade agreements, supports U.S.-made products, and outlines the need for accuracy and completeness in the submitted proposals to avoid disqualification. The RFP is being managed by the Network Contracting Office 15 based in Leavenworth, KS, further reinforcing the VA's commitment to ensuring the availability of essential medications for veterans.
    52.225-6 TRADE AGREEMENTS CERTIFICATE.docx
    The Trade Agreements Certificate (FAR 52.225-6) outlines the certification requirements for offerors in government solicitations regarding the origin of the products offered. It mandates that each end product, unless specified otherwise, must be a U.S.-made or designated country end product. Offerors are required to list any products that do not conform to this requirement, detailing the country of origin. The evaluation of offers will be conducted following the Federal Acquisition Regulation, particularly for line items under the WTO Government Procurement Agreement (GPA), which allows for the evaluation of U.S.-made or designated country products without the constraints of the Buy American statute. Generally, only offers for compliant products will be considered unless a Contracting Officer identifies a lack of sufficient proposals that meet the outlined requirements. This provision emphasizes the importance of safeguarding domestic manufacturing and ensuring compliance with international trade agreements in federal procurement processes.
    S02_Solicitation_Attachment_Pricing SpreadSheet_RFQ_36C77025Q0028.xlsx
    The document outlines a Request for Quotation (RFQ) from the Department of Veterans Affairs, specifically for the procurement of Metformin HCL 500mg 24HR SA Tablets, with an estimated issue date of October 11, 2024, and a closing date on October 21, 2024, at 9:00 AM CST. The RFQ details the required quantities organized by packaging and presents compliance requirements with the Drug Supply Chain Security Act (DSCSA). Suppliers must provide a state wholesale distributor license indicating compliance with DSCSA, along with other documentation such as a signed SF1449 cover page and a completed Trade Agreements Certificate. The delivery is expected by November 7, 2024. The document also lists ship-to addresses for various VA CMOP locations. The RFQ emphasizes the importance of adherence to the DSCSA for all trading partners to ensure safe and effective drug distribution.
    Similar Opportunities
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0027 770-25-1-8-1-0015 -National CMOP FENOFIBRATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Fenofibrate pharmaceuticals, specifically 145 mg, under solicitation number 36C77025Q0027. The procurement involves delivering various quantities of the medication to multiple Consolidated Mail Outpatient Pharmacy (CMOP) locations, emphasizing compliance with federal regulations, including the Drug Supply Chain Security Act (DSCSA) and the Buy American Act. This initiative is crucial for ensuring timely access to essential pharmaceuticals for veterans, reflecting the VA's commitment to quality healthcare services. Interested vendors must submit their quotes, along with required documentation, by October 18, 2024, at 9:00 AM Central Time, with an anticipated award date of October 22, 2024. For further inquiries, vendors can contact Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    Metformin HCL
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is planning to issue a national requirements contract for Metformin HCL ER. The contract will establish a national supply source to provide Metformin HCL ER Tablets in various quantities and bottle sizes. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The items will be purchased by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. The solicitation will be posted on DLA Bid Board System (DIBBS) and Sam.gov. Interested parties should contact Christopher Newman for any questions/comments. The projected solicitation date is August 2021.
    6505--770-24-4-801-0686 -National CMOP CLINDAMYCIN -(VA-24-00096153)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Clindamycin PO4 1% Top Swab for delivery to multiple Compounding Medication Outpatient Pharmacies (CMOP) across the country. This procurement aims to secure approximately 3,584 units of the specified pharmaceutical product, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). The goods are essential for the VA's healthcare services, supporting the treatment of various medical conditions. Interested vendors must submit their quotations by September 6, 2024, including a signed SF1449 cover page, a price schedule, proof of a valid State Wholesale Distributor License, and a Buy American Act Certificate. For further inquiries, vendors can contact Kelley Cunningham at kelley.cunningham@va.gov or call 913-684-0140.
    6505--Tadalafil Tablets (VA-24-00107372)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79724R0033 concerning the procurement of Tadalafil Tablets, intended for various federal entities, including the Department of Defense and the Bureau of Prisons. The selected contractor will be responsible for ensuring a continuous supply of Tadalafil, with a contract period of one year and four optional annual extensions, and must adhere to specific labeling and packaging requirements, including safety features for the bottles. This procurement is crucial for meeting the medication needs of veterans and other federal healthcare programs, with an estimated total annual requirement of approximately 322,854 bottles across various strengths. Interested parties should direct inquiries to Contract Specialist Billy Fong at billy.fong@va.gov, and proposals are due by November 12, 2024, following the RFP release on or about October 29, 2024.
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for a contract to supply Calcitonin gene-related peptides (CGRP) as part of its Pharmaceutical Prime Vendor (PPV) Program. The procurement aims to establish a reliable source of these pharmaceutical products, ensuring compliance with federal regulations, including the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). This initiative is crucial for maintaining consistent supply and quality control across VA medical facilities. Interested offerors must submit their proposals by October 31, 2024, at 2:30 PM CT, and can direct inquiries to Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov.
    770-25-1-801-0005 - National CMOP LUBRICATING (PF) OPH OINT (VA-25-00008855)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Lubricating Ophthalmic Ointment for the National Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0013. The procurement requires vendors to submit comprehensive quotes that include a signed RFQ cover page, detailed pricing schedules, proof of licensing, and documentation of authorized dealership status for the products. This contract is crucial for ensuring the availability of essential pharmaceutical products that meet federal regulations, including compliance with the Drug Supply Chain Security Act and FDA standards for therapeutic equivalence. Interested vendors must submit their quotations by October 18, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Ketoconazole 2% Cream
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the supply of Ketoconazole 2% Cream, a pharmaceutical product essential for treating various skin conditions. Offerors are required to submit pricing for the base year and four option years, ensuring compliance with the Cost Recovery Fee of 0.5%, and must provide unique National Drug Codes (NDC) for their proposed products. This procurement aims to establish a reliable supply chain for pharmaceutical needs while adhering to federal procurement standards, emphasizing the importance of FDA cGMP compliance for manufacturers or authorized distributors. Interested parties should contact Contract Specialist Michael J Olszewski at Michael.Olszewski@va.gov for further details regarding the solicitation process.
    Metformin HCL ER
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is procuring Metformin HCL ER. Metformin HCL ER is a drug used to treat type 2 diabetes. This procurement is being conducted by DLA TROOP SUPPORT. For more information, contact Christopher Newman at christopher.newman@dla.mil or 2157372905.
    Dimethyl Fumarate DR Presolicitation
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.